The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
After three years, only a third of 2,000 U.S. hospitals reviewed were in compliance with the Hospital Price Transparency Rule of 2021, says a new PRA report, which puts some of the blame on feds for not enforcing the rule.
Here is a deeper look at five areas where automated employee benefits can reap rewards for employers and their workforce and where benefits advisors can help guide change.
With drug shortages at an all-time high, the Senate Finance Committee wants to create a new program to incentivize improved contracting and purchasing practices in the supply chain by offering bonuses to hospitals and providers.
Employers must act upon this price information to redesign their health plans to better align hospital prices with the value of care provided, since price transparency alone will not lead to changes, according to a new RAND report.
In the first quarter of 2024, 323 drugs were in short supply, up from the previous high of 320 in 2014, says the University of Utah Drug Information Service, as policymakers propose giving the FDA more power over Big Pharma.
Because there currently is no standard fee schedule or uniform approach, calculating trauma activation fees is left to the discretion of each individual trauma center.
The escalating warfare over pricing, which stems from hospital price transparency regulations that have allowed hospitals to compare reimbursement rates with one another, can leave patients without continuity of coverage.
The National Alliance of Healthcare Purchaser Coalitions, which represents large employers that purchase health coverage, identifies and debunks top hospital inaccuracies around high, rapidly rising, prices, in a new report.